Skip to main content

Table 2 Base case cost-effectiveness results

From: A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury

Treatment

Costs

QALYs

Incremental Costs

Incremental QALYs

ICER (QALY)

No tranexamic acid

£16,019

3.0656

   

Tranexamic acid

£16,115

3.0854

£96.69

0.0198

£4,885